Tangible Assets
Tangible assets that demand judgment, network, and strategic integration - far beyond standard valuation models.
Overview
The most interesting parts of wealth are rarely the simplest ones.
Private company stakes, art collections, horse holdings, and growth investments all share one thing: they cannot be valued, structured, or embedded into an overall strategy with standard methods.
At Wealthgate, tangible assets are not treated as a footnote, but as what they often are: the core of a life's work.
From practice
A world that cannot be captured with standard methods.
Each area requires its own judgment, its own network, and an understanding that goes far beyond the purely financial.
Your Wealthgate Specialist
Personal care begins with personal responsibility.
Ralph Lück
Vice President Wealth Management
Ralph Lück has been active as a single family officer for more than 12 years and has directly overseen the strategic management of complex wealth in the areas of tangible assets, private markets and finance.
He has guided entrepreneurial families through different market and business phases. He is also active as an advisory board and supervisory board member. His approach: business assets and private assets are two sides of the same life’s work. He thinks both together.
„Wealth serves concrete goals and should reliably and predictably finance specific purposes."
Related Insights
We combine the expertise of our team with reliable assessments from practice to create a relevant advantage for our clients.
Lutz Meschke helps shape WEALTHGATE's strategic direction
Former Porsche CFO and Deputy Chairman Lutz Meschke has been a shareholder at WEALTHGATE since 2018 and is making his role public for the first time.
Auswirkungen des Iran-Kriegs / Ölpreisschocks auf den Biotechsektor
Geopolitische Eskalationen und steigende Ölpreise sorgen kurzfristig für Verunsicherung an den Kapitalmärkten. Historische Erfahrungen zeigen jedoch: Der Biotech‑ und Gesundheitssektor ist strukturell weniger abhängig von Energiepreisen und erholt sich nach anfänglichen Rückschlägen häufig schneller als zyklische Branchen. In unserem aktuellen Update ordnen wir die Situation ein und zeigen, warum volatile Marktphasen im Biotechbereich auch Chancen …
Fondsupdate Februar 2026
Wir freuen uns, Ihnen das aktuelle Monatsupdate für den WEALTHGATE Multi Asset zur Verfügung zu stellen: Monatliches Fondsupdate Februar 2026 Der Bericht bietet Ihnen wie gewohnt eine kompakte Übersicht zur Fondsentwicklung, zu relevanten Marktbewegungen sowie zu strategischen Anpassungen innerhalb des Portfolios. Für Rückfragen oder einen vertiefenden Austausch stehen wir Ihnen jederzeit gerne zur Verfügung.